Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 51
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Int J Urol ; 29(12): 1498-1504, 2022 12.
Artículo en Inglés | MEDLINE | ID: mdl-36102589

RESUMEN

OBJECTIVES: To estimate the surgical and quality-of-life outcomes of artificial urinary sphincter implantation in patients with diabetes mellitus (DM). Subanalyses were performed using the same population as that in our previous multicenter, prospective, observational study. METHODS: A total of 135 male patients who underwent primary artificial urinary sphincter implantation were divided into two groups: those with and without DM. The revision-free rates, that is, the percentage of patients who did not require revision surgery, were compared between patients with and without DM. The number of urinary pads required per day, International Consultation on Incontinence Questionnaire-Short Form, and King's Health Questionnaire were used to compare the continence status and quality of life (QOL) between the two groups preoperatively and at 1, 3, and 12 months after surgery. RESULTS: Revision-free rates were significantly lower in the DM group (83.9%, 77.4%, and 67.8% at 1, 2, and 3 years after implantation, respectively) than in the non-DM group (95.5%, 92.5%, and 85.5% at 1, 2, and 3 years after implantation, respectively). Both continence status and QOL, assessed by questionnaires, markedly improved after surgery in patients with and without DM. CONCLUSIONS: Despite differences in the durability of the artificial urinary sphincters, patients with DM can obtain as much benefit from artificial urinary sphincter implantation regarding continence and quality-of-life improvement as patients without DM. Therefore, DM was not considered a comorbidity that contraindicated artificial urinary sphincter implantation. Additional large-scale studies are required to verify our findings.


Asunto(s)
Diabetes Mellitus , Incontinencia Urinaria de Esfuerzo , Esfínter Urinario Artificial , Humanos , Masculino , Esfínter Urinario Artificial/efectos adversos , Calidad de Vida , Estudios Prospectivos , Resultado del Tratamiento , Diabetes Mellitus/epidemiología , Incontinencia Urinaria de Esfuerzo/cirugía , Estudios Retrospectivos , Implantación de Prótesis/efectos adversos
2.
Tohoku J Exp Med ; 252(4): 329-337, 2020 12.
Artículo en Inglés | MEDLINE | ID: mdl-33268602

RESUMEN

Disasters influence various health conditions; however, little has been reported about urinary symptoms. The objective of this study is to evaluate whether night-time urinary frequency was influenced by the Great East Japan Earthquake (GEJE) in March 2011. We also evaluated seasonal variation of night-time frequency, which may affect the primary objective. A retrospective chart review was conducted on 300 evaluable patients who resided in the impacted area: 263 men with benign prostatic hyperplasia and/or overactive bladder and 37 women with overactive bladder. Data concerning night-time frequency were collected repeatedly every three months from March 2009 until March 2014, then compared yearly and seasonally among same patients. In addition, night-time frequency was analyzed for potential relations to sex, age, comorbidities, and whether residences had been destroyed. There was a significant increase of night-time frequency during 2011-2013 when compared yearly with 2009 and 2010. In seasonal comparisons of the entire period, night-time frequency was greater during autumn and winter compared with summer. In quarterly comparisons, a sudden increase was not observed after the GEJE, but night-time frequency was increased significantly in spring, summer and autumn in 2011 when compared with the corresponding seasons in 2010. While hypertension was related to exacerbation of night-time frequency during winter, we did not find any factors associated with increase after the disaster out of sex, age, comorbidities or residential situations. In conclusion, night-time urinary frequency is increased shortly after the GEJE and remains elevated for the following three years along with seasonal variation.


Asunto(s)
Ritmo Circadiano/fisiología , Terremotos , Estaciones del Año , Micción/fisiología , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Hipertensión/epidemiología , Japón/epidemiología , Estudios Longitudinales , Masculino , Prevalencia
3.
J Urol ; 199(1): 245-250, 2018 01.
Artículo en Inglés | MEDLINE | ID: mdl-28823767

RESUMEN

PURPOSE: We performed a multicenter, prospective, observational study to assess outcomes, including changes in continence status and quality of life, after artificial urinary sphincter implantation. MATERIALS AND METHODS: Prospectively enrolled in this study were 135 patients who underwent primary AMS 800™ implantation between 2011 and 2014 at 1 of 5 institutions. Perioperative complications were categorized according to the Clavien-Dindo classification. We estimated the revision-free rate, that is the incidence of patients who did not undergo artificial urinary sphincter revision surgery. Cox regression analysis was performed to identify patient risk factors for revision surgery. The number of pads needed per day, ICIQ-SF (International Consultation on Incontinence Questionnaire-Short Form) and KHQ (King's Health Questionnaire) were used to estimate continence status and quality of life preoperatively, and 1, 3 and 12 months postoperatively. RESULTS: The artificial urinary sphincter was implanted without major complications. The revision-free rate 1, 2 and 3 years after implantation was 94%, 88% and 81%, respectively. Diabetes mellitus and poor preoperative American Society of Anesthesiologists® physical status were significant risk factors for revision surgery. Continence status and quality of life were markedly improved after surgery. However, ICIQ-SF and some KHQ items showed slight but significant deterioration at 12 months compared with scores 1 month after surgery. CONCLUSIONS: Artificial urinary sphincter implantation is a safe and durable procedure that substantially improves patient continence status and quality of life soon after surgery. Our results indicate that patients start to experience slight but noticeable deterioration in continence status and quality of life relatively early (within 1 year) after surgery. This finding might be helpful with appropriately counseling patients who undergo artificial urinary sphincter implantation.


Asunto(s)
Complicaciones Intraoperatorias/epidemiología , Medición de Resultados Informados por el Paciente , Complicaciones Posoperatorias/epidemiología , Incontinencia Urinaria de Esfuerzo/cirugía , Esfínter Urinario Artificial/efectos adversos , Procedimientos Quirúrgicos Urológicos/instrumentación , Anciano , Humanos , Incidencia , Pañales para la Incontinencia/estadística & datos numéricos , Masculino , Satisfacción del Paciente , Periodo Perioperatorio , Complicaciones Posoperatorias/etiología , Estudios Prospectivos , Calidad de Vida , Reoperación/estadística & datos numéricos , Factores de Tiempo , Resultado del Tratamiento , Procedimientos Quirúrgicos Urológicos/efectos adversos , Procedimientos Quirúrgicos Urológicos/métodos
4.
BJU Int ; 117(3): 450-5, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25684579

RESUMEN

OBJECTIVE: To perform a longitudinal investigation of the correlation between functional recovery and sex hormone concentrations after radical prostatectomy (RP). PATIENTS AND METHODS: A total of 72 consecutive patients undergoing RP between January 2012 and June 2013 were prospectively included and serially followed after surgery for comparative analysis. Their luteinizing hormone (LH) and total testosterone (TT) concentrations were measured before surgery and 3 and 12 months after surgery. They also filled out a health-related quality of life questionnaire before and at 1, 3, 6 and 12 months after surgery. RESULTS: The mean LH concentration increased from 4.28 U/L at baseline to 5.53 U/L at 3 months and remained high at 12 months after RP (both P < 0.001). There were no significant changes in the TT concentration after RP. LH at baseline was negatively correlated with the urinary function (UF) score at 3 and 12 months after RP (P = 0.030 and 0.032, respectively). After RP, subjects with high baseline LH (n = 37) were more likely than those with low LH concentrations to report lower UF scores (P = 0.014). Multivariate analysis of variance in an interaction of time × LH concentration for UF scores indicated a significant relationship between changes in UF score and LH concentration (P = 0.004). CONCLUSIONS: Radical prostatectomy affects sex hormones by increasing LH concentrations, while TT concentrations remain stable after surgery. Baseline LH concentrations are significantly associated with the recovery of urinary outcomes after RP.


Asunto(s)
Hormona Luteinizante/metabolismo , Prostatectomía/métodos , Neoplasias de la Próstata/cirugía , Retención Urinaria/cirugía , Anciano , Humanos , Masculino , Persona de Mediana Edad , Cuidados Posoperatorios , Cuidados Preoperatorios , Estudios Prospectivos , Neoplasias de la Próstata/sangre , Neoplasias de la Próstata/fisiopatología , Calidad de Vida , Recuperación de la Función , Testosterona/metabolismo , Retención Urinaria/sangre , Retención Urinaria/fisiopatología
5.
Tohoku J Exp Med ; 237(4): 317-21, 2015 12.
Artículo en Inglés | MEDLINE | ID: mdl-26633178

RESUMEN

Ductal adenocarcinoma is an unusual variant of adenocarcinoma of the prostate with a poorly understood natural history, and its treatment is not well defined. Ductal adenocarcinoma is often diagnosed at an advanced stage, because no specific tumor markers are known. Docetaxel has been used for acinar adenocarcinoma of the prostate, a common type of prostate cancer, but it is largely ineffective for ductal adenocarcinoma. Earlier studies suggested that the chemotherapy with gemcitabine and cisplatin might be effective for ductal adenocarcinoma. Here we report two patients with ductal adenocarcinoma of the prostate that did not respond to docetaxel, but responded to the gemcitabine/cisplatin chemotherapy. Patient 1 was a 59-year-old man who had lung metastasis despite androgen deprivation therapy with undetectable levels of prostate-specific antigen and who presented with brain metastasis during docetaxel chemotherapy. Pathological examination of the resected brain tumor revealed ductal adenocarcinoma with positive immunostaining for carcinoembryonic antigen. The gemcitabine/cisplatin chemotherapy achieved partial response of the lung metastasis with serum carcinoembryonic antigen levels decreasing from 11.4 ng/mL to 2.9 ng/mL. Patient 2 was a 69-year-old man with lung metastasis. Local progression appeared during androgen deprivation therapy, and the subsequent transurethral biopsy revealed ductal adenocarcinoma with positive immunostaining for neuron-specific enolase. Bone and distant lymph node metastasis appeared despite docetaxel chemotherapy. Six courses of the gemcitabine/cisplatin chemotherapy achieved partial response of metastatic lesions, with serum neuron-specific enolase levels decreasing from 118 ng/mL to 2.6 ng/mL. The gemcitabine/cisplatin chemotherapy is a potential option for treatment of advanced ductal adenocarcinoma of the prostate.


Asunto(s)
Adenocarcinoma/tratamiento farmacológico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Neoplasias de la Próstata/tratamiento farmacológico , Adenocarcinoma/patología , Anciano , Antimetabolitos Antineoplásicos/administración & dosificación , Antineoplásicos/administración & dosificación , Antígeno Carcinoembrionario/análisis , Cisplatino/administración & dosificación , Desoxicitidina/administración & dosificación , Desoxicitidina/análogos & derivados , Resultado Fatal , Humanos , Neoplasias Pulmonares/secundario , Masculino , Persona de Mediana Edad , Fosfopiruvato Hidratasa/sangre , Neoplasias de la Próstata/patología , Gemcitabina
6.
Int Urogynecol J ; 25(12): 1721-7, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-24988889

RESUMEN

INTRODUCTION AND HYPOTHESIS: Effects of tadalafil, a phosphodiesterase type 5 inhibitor, on the urethral continence reflex induced by sneezing were investigated. METHODS: The amplitude of urethral pressure responses during sneezing (A-URS) and urethral baseline pressure (UBP) were measured in female rats using a microtransducer-tipped catheter. Sneeze leak-point pressure (S-LPP), defined as the lowest amount of pressure required to induce fluid leakage from the urethral orifice during sneezing, was measured in rats with stress urinary incontinence (SUI) induced by vaginal distension. Values were determined before and after tadalafil administration. RESULTS: Tadalafil dose dependently and significantly decreased A-URS and S-LPP. At the highest dose tested (6.0 mg/kg), A-URS and S-LPP decreased from 49.7 to 32.3 and from 63.9 to 44.2 cmH2O, respectively, whereas UBP did not significantly change. CONCLUSIONS: Tadalafil attenuated the sneeze-induced urethral continence reflex by relaxing the striated muscles of the external urethral sphincter.


Asunto(s)
Carbolinas/uso terapéutico , Inhibidores de Fosfodiesterasa 5/uso terapéutico , Enfermedades Uretrales/tratamiento farmacológico , Enfermedades Uretrales/fisiopatología , Incontinencia Urinaria de Esfuerzo/tratamiento farmacológico , Incontinencia Urinaria de Esfuerzo/fisiopatología , Animales , Carbolinas/farmacología , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Femenino , Relajación Muscular/efectos de los fármacos , Relajación Muscular/fisiología , Músculo Liso/efectos de los fármacos , Músculo Liso/fisiopatología , Inhibidores de Fosfodiesterasa 5/farmacología , Ratas , Ratas Sprague-Dawley , Reflejo/efectos de los fármacos , Reflejo/fisiología , Tadalafilo , Resultado del Tratamiento , Uretra/efectos de los fármacos , Uretra/fisiopatología
7.
Int J Urol ; 21(12): 1220-6, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25143229

RESUMEN

OBJECTIVES: To assess long-term health-related quality of life in patients undergoing radical prostatectomy. METHODS: A total of 120 patients with at least 5 years of follow up after radical prostatectomy were included in the present study. Health-related quality of life outcomes were assessed using three questionnaires, the Short Form 36-Item Health Survey, the University of California, Los Angeles Prostate Cancer Index and the International Prostate Symptom Score. RESULTS: A total of 91 patients (73%) responded at a median follow-up time of 102 months (range 85-123 months). Among general health-related quality of life domains, mental and role composite summary score remained stable throughout the follow-up period. At the final survey, no significant differences were observed in any of the domains compared with the age-matched average score of the Japanese population. Although the slight decrease in urinary function scores and International Prostate Symptom Score beyond 5 years postoperatively compared with 5 years, the differences were not significant. The sexual function summary score showed a substantially lower score just after radical prostatectomy and remained at a deteriorated level (P < 0.001). Responders at the final survey were more likely to report favorable general, urinary and sexual outcomes at 60 months compared with non-responders. CONCLUSIONS: When taking age-related changes into account, general health-related quality of life seems to remain stable in the long term after radical prostatectomy: patients with favorable health-related quality of life outcomes during the first 5 years after radical prostatectomy maintain favorable outcomes thereafter.


Asunto(s)
Estado de Salud , Prostatectomía , Neoplasias de la Próstata/cirugía , Calidad de Vida , Anciano , Estudios de Seguimiento , Humanos , Japón , Masculino , Persona de Mediana Edad , Periodo Posoperatorio , Neoplasias de la Próstata/psicología , Encuestas y Cuestionarios , Factores de Tiempo , Resultado del Tratamiento
8.
Int J Urol ; 21(11): 1114-9, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-24962105

RESUMEN

OBJECTIVES: To examine whether low-dose maintenance gemcitabine-carboplatin chemotherapy is beneficial for patients with metastatic urothelial carcinoma. METHODS: We retrospectively reviewed the records of 36 patients with metastatic urothelial carcinoma who received first-line chemotherapy (gemcitabine/cisplatin, gemcitabine/carboplatin, or methotrexate/vinblastine/adriamycin/cisplatin) between 2006 and 2012. Those who had responded, but were unable to tolerate ongoing first-line chemotherapy, had been switched to low-dose maintenance chemotherapy consisting of 1 g/m(2) of gemcitabine and area under the curve 2-4 of carboplatin given on day 1 of a 6-week cycle, and were continued unless disease progression was seen. RESULTS: After a median of three cycles of first-line chemotherapy, 17 patients had been switched to low-dose maintenance chemotherapy. The median age was 70 years (range 56-79 years), and 12 patients (70.6%) had renal dysfunction (creatinine clearance <60 mL/min). The median number of cycles of low-dose maintenance chemotherapy was six (range 2-22), and the median survival time from initiation of first-line chemotherapy was 12 months (range 4-32 months). Adverse events requiring hospitalization were seen in three patients, but all of them recovered within a few days with conservative treatment. Seven patients discontinued within 9 months, whereas 10 patients continued on low-dose maintenance chemotherapy for ≥9 months. Patients with only lymph node metastases or who had a good response to previous first-line chemotherapy were likely to be able to continue low-dose maintenance chemotherapy. CONCLUSIONS: Low-dose maintenance gemcitabine-carboplatin chemotherapy might represent an alternative for patients with metastatic urothelial carcinoma not tolerating continuous first-line standard chemotherapy regimens.


Asunto(s)
Antineoplásicos/administración & dosificación , Carboplatino/administración & dosificación , Carcinoma de Células Transicionales/tratamiento farmacológico , Desoxicitidina/análogos & derivados , Neoplasias Urológicas/tratamiento farmacológico , Anciano , Antineoplásicos/efectos adversos , Protocolos de Quimioterapia Combinada Antineoplásica , Carboplatino/efectos adversos , Desoxicitidina/administración & dosificación , Desoxicitidina/efectos adversos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Gemcitabina
9.
Jpn J Clin Oncol ; 43(7): 734-9, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23619987

RESUMEN

OBJECTIVE: We investigated the efficacy and toxicity of a docetaxel, ifosfamide and nedaplatin regimen as salvage therapy for patients with advanced testicular germ cell tumor. METHODS: Eleven patients with advanced germ cell tumor refractory or relapsed after cisplatin-based chemotherapy were treated using docetaxel, ifosfamide and nedaplatin. The docetaxel, ifosfamide and nedaplatin regimen comprised docetaxel (75 mg/m(2)) on Day 1, ifosfamide (2 g/m(2)) on Days 1-3 and nedaplatin (75 mg/m(2)) on Day 2 of a 3-week cycle. RESULTS: Ten (91%) of the 11 patients achieved favorable responses, including complete response in one case and partial response in nine cases. Nine (81%) of the 11 patients have continued to show no evidence of disease after docetaxel, ifosfamide and nedaplatin therapy followed by subsequent surgical resection, with a median follow-up period of 52 months. One patient died of the disease 3 months after completing docetaxel, ifosfamide and nedaplatin chemotherapy. One patient was lost to follow-up with a status of alive with disease. Ten (91%) of the 11 patients developed Grade 4 leukopenia, which was managed using granulocyte colony-stimulating factor. No patients developed sensory neuropathy or renal dysfunction. CONCLUSIONS: The docetaxel, ifosfamide and nedaplatin regimen was efficacious and well-tolerated as salvage chemotherapy for patients with advanced germ cell tumor.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Neoplasias de Células Germinales y Embrionarias/tratamiento farmacológico , Terapia Recuperativa/métodos , Neoplasias Testiculares/tratamiento farmacológico , Adulto , Anciano , Docetaxel , Esquema de Medicación , Resistencia a Antineoplásicos , Humanos , Ifosfamida/administración & dosificación , Masculino , Persona de Mediana Edad , Neoplasias de Células Germinales y Embrionarias/patología , Compuestos Organoplatinos/administración & dosificación , Recurrencia , Taxoides/administración & dosificación , Neoplasias Testiculares/patología , Resultado del Tratamiento
10.
J Infect Chemother ; 19(6): 1193-5, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23605319

RESUMEN

Encrusted cystitis is characterized by chronic inflammation of the bladder with encrustation of the mucosa, induced by urea-splitting bacterial infection. However, encrusted cystitis in itself is not well known. We report a case of encrusted cystitis causing postrenal failure. An 81-year-old man with pneumonia complained of pollakisuria, micturition pain, and gross hematuria. Bladder calculi were found, and transurethral lithotripsy was performed. However, because his symptoms did not improve, he was referred to our hospital. His urine pH was 8.5, and urine culture grew Corynebacterium and Proteus. Computerized tomography and cystoscopy revealed bladder "encrustation," caused by bladder wall calcification, and bilateral hydronephrosis. Hence, he was diagnosed with postrenal failure resulting from encrusted cystitis. Immediate bilateral nephrostomy was constructed, with continuous bladder perfusion with an acid solution for acidification of his urine, followed by intravenous administration of ceftriaxone. After 2 weeks of treatment, the calcification disappeared and his bladder mucosa was normalized. The postrenal failure also improved and thus the nephrostomy tubes were removed. Encrusted cystitis is curable by prompt treatment with acidification of urine. Therefore, precise diagnosis and therapy are critical.


Asunto(s)
Lesión Renal Aguda/etiología , Cistitis/fisiopatología , Lesión Renal Aguda/microbiología , Anciano de 80 o más Años , Antibacterianos/uso terapéutico , Calcinosis/diagnóstico por imagen , Calcinosis/patología , Calcinosis/fisiopatología , Corynebacterium/aislamiento & purificación , Infecciones por Corynebacterium/microbiología , Infecciones por Corynebacterium/fisiopatología , Cistitis/microbiología , Técnicas de Diagnóstico Urológico , Humanos , Masculino , Estomía , Neumonía/fisiopatología , Radiografía
11.
J Sex Med ; 9(9): 2448-56, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22616799

RESUMEN

INTRODUCTION: There were few studies about the relationship between sexual desire (SD) and radical prostatectomy (RP). AIMS: We assessed the relationships between RP and quality of life (QOL) according to the preoperative SD. MAIN OUTCOME MEASURE: General QOL was measured with Short Form 36. Sexual function and bother were measured with the University of California, Los Angeles Prostate Cancer Index (PCI). Changes of postoperative SD were also evaluated using PCI. METHODS: We analyzed data from 285 men who underwent RP and were prospectively enrolled into a longitudinal cohort study. Patients were divided into two groups according to whether they had SD at baseline, which is addressed in the PCI questionnaire: a low SD (LSD) group and a high SD (HSD) group. The assessments were completed before treatment and 3, 6, 12, 24, and 60 months after RP. RESULTS: Of the 244 men, 52% had high or a fair level of SD before RP, whereas 48% reported that the level of their SD was low. The HSD group reported better sexual function and sexual bother scores than the LSD group at baseline (both P < 0.001). Fifty-one percent of the HSD group reported that SD at 3 months was poor or very poor, which did not return to the preoperative level at all postoperative time points. Nearly 20% of the LSD group regained higher SD after RP than the baseline level. The HSD group showed worse sexual bother scores than the baseline throughout the postoperative follow-up (P < 0.001). However, the LSD group demonstrated equivalent sexual bother scores after RP compared with the baseline. CONCLUSIONS: RP adversely affected SD as well as sexual function and sexual bother. The patients who had HSD experienced greater distress concerning their sexual dysfunction postoperatively than those with LSD.


Asunto(s)
Libido , Prostatectomía , Calidad de Vida , Anciano , Estudios de Cohortes , Humanos , Estudios Longitudinales , Masculino , Análisis Multivariante , Inhibidores de Fosfodiesterasa 5/uso terapéutico , Periodo Posoperatorio , Periodo Preoperatorio , Prostatectomía/métodos , Neoplasias de la Próstata/cirugía
12.
Int J Gynecol Cancer ; 22(9): 1591-6, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-23051958

RESUMEN

OBJECTIVE: In this study, by monitoring the varied distributions of nerve fascicles using intraoperative electrical stimulation (IES), we sought to establish an individualized operation based on the patient's unique nerve distribution pattern, and to determine whether this technique would result in a higher preservation rate. MATERIALS/METHODS: Radical hysterectomy was performed from 2002 to 2010. Patients in group A are the 48 cases from 2002 to 2007 in which nerve-sparing radical hysterectomy using IES as our previous report was performed. Patients in group B are the 38 cases from 2008 to 2010 in which we used our new method, which was individualized to each patient. Urodynamic study (UDS) was used to confirm nerve preservation. Nerve preservation was defined as confirming distinct detrusor contraction during urinary voiding. RESULTS: In group B, nerve preservation rate was higher than in group A (75% vs 9 0%, P = 0.067). We classified the case-by-case nerve anatomy as whether the nerve fascicle was mainly on the medial side or on the lateral side of the deep uterine vein. The lateral type anatomy was observed unilaterally in 6 cases and bilaterally in 1 case. In summary, the lateral type anatomy was observed in 8 (29%) of 28 sides. In the cases evaluated by UDS, the positive predictive value of IES was 95% in group A and 100% in group B. CONCLUSIONS: Our method of IES showed a high positive predictive value of nerve preservation as confirmed by UDS. By delineating the nerve tract in detail using IES, it is possible to individualize the operation based on each patient's anatomy, with an improved nerve preservation rate.


Asunto(s)
Carcinoma de Células Escamosas/cirugía , Histerectomía/métodos , Medicina de Precisión/métodos , Neoplasias del Cuello Uterino/cirugía , Adenocarcinoma/epidemiología , Adenocarcinoma/fisiopatología , Adenocarcinoma/cirugía , Adulto , Carcinoma de Células Escamosas/epidemiología , Carcinoma de Células Escamosas/fisiopatología , Estimulación Eléctrica/métodos , Femenino , Humanos , Histerectomía/efectos adversos , Histerectomía/estadística & datos numéricos , Periodo Intraoperatorio , Persona de Mediana Edad , Modelos Biológicos , Complicaciones Posoperatorias/epidemiología , Complicaciones Posoperatorias/prevención & control , Sistema Urinario/inervación , Sistema Urinario/fisiopatología , Sistema Urinario/cirugía , Urodinámica/fisiología , Enfermedades Urológicas/epidemiología , Enfermedades Urológicas/etiología , Enfermedades Urológicas/prevención & control , Neoplasias del Cuello Uterino/epidemiología , Neoplasias del Cuello Uterino/fisiopatología
13.
Hinyokika Kiyo ; 58(12): 679-82, 2012 Dec.
Artículo en Japonés | MEDLINE | ID: mdl-23328163

RESUMEN

A right renal cyst was found in a 69-year-old man with stage IV chronic kidney disease on abdominal ultrasonography performed to investigate a right upper abdominal swelling. Aspiration cytology of the cyst revealed no malignancy, but malignancy could not be ruled out on magnetic resonance imaging because of the cyst's wall thickness and heterogeneous contents. At one-year of follow-up, emergent abdominal surgery was performed due to incidental perforation of ascending colon diverticulitis. At that time, cystic fenestration was performed because the large renal cyst obstructed the operative procedure. Pathological examination showed type-1 papillary renal cell carcinoma, and radical nephrectomy was performed after the patient's general condition improved. Hemodialysis was started after the operation, and there has been no disease recurrence for two years.


Asunto(s)
Carcinoma de Células Renales/diagnóstico , Hemorragia/diagnóstico , Enfermedades Renales Quísticas/diagnóstico , Neoplasias Renales/diagnóstico , Anciano , Carcinoma de Células Renales/patología , Diagnóstico Diferencial , Humanos , Neoplasias Renales/patología , Masculino
14.
Int J Urol ; 18(3): 212-8, 2011 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21198945

RESUMEN

OBJECTIVES: The aim of this study was to measure the prevalence of and risk factors for overactive bladder (OAB) in the elderly. METHODS: A cross-sectional study of elderly subjects was conducted by analyzing data from a community-based Comprehensive Geriatric Assessment on people aged 70 years or older. Trained interviewers performed face-to-face interviews for the assessment of urological symptoms. OAB definition was based on urgency and eight or more episodes of urination per day. The subjects completed a self-administered questionnaire including lifestyle evaluation, Geriatric Depression Scale, Mini-Mental Status Examination and medical history. Brachial-ankle pulse wave velocity was recorded to assess atherosclerotic disease. The analysis included 833 subjects, after the exclusion of 115 subjects who provided insufficient information. RESULTS: Based on the definition of OAB, 153 subjects (18.4%) were identified as having OAB. Univariate analysis showed a significant association between OAB and depressive symptoms. Multivariate analysis showed that the risk of having OAB was significantly higher in subjects with depressive symptoms, current drinkers, and overweight subjects with odds ratios of 2.37 (1.60-3.52, 95% confidence interval), 1.65 (1.04-2.62), and 1.51 (1.02-2.24), respectively. CONCLUSIONS: This is the first report to show an association between OAB and depressive symptoms and alcohol intake in an epidemiological study of elderly people. The reasons for these correlations remain unclear, but should be the foci of future OAB studies.


Asunto(s)
Depresión/epidemiología , Vejiga Urinaria Hiperactiva/epidemiología , Anciano , Anciano de 80 o más Años , Consumo de Bebidas Alcohólicas/epidemiología , Consumo de Bebidas Alcohólicas/psicología , Índice Tobillo Braquial , Aterosclerosis/epidemiología , Aterosclerosis/psicología , Depresión/psicología , Femenino , Encuestas Epidemiológicas , Humanos , Entrevistas como Asunto , Masculino , Sobrepeso/epidemiología , Sobrepeso/psicología , Prevalencia , Características de la Residencia , Factores de Riesgo , Encuestas y Cuestionarios , Vejiga Urinaria Hiperactiva/psicología
15.
Int J Urol ; 18(11): 762-7, 2011 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-21914001

RESUMEN

OBJECTIVE: To report a single-center experience with laparoscopic simultaneous bilateral adrenalectomy (LSBA) and to evaluate its safety, surgical outcomes, and potential indications of the procedure. METHODS: A total of 21 patients underwent LSBA between 2000 and 2010 at our institution. Four patients had bilateral Cushing's syndrome (CS), two had bilateral pheochromocytoma, and one had a bilateral metastatic tumor. Eleven patients had unilateral or bilateral aldosterone-producing adenoma (APA), associated with CS or subclinical CS. Three patients had unilateral APA with contralateral non-functioning adenoma. Partial adrenalectomy was performed first by using with four ports. After the excision of one gland, the contralateral gland was removed after repositioning of the patient. RESULTS: LSBA was completed in all 21 patients without major complications. Mean operative time was 329.7 min and the estimated blood loss was 94.1 mL. Mean tumor size was 21.8 mm. Of the 16 patients receiving an adrenal-sparing procedure, nine of 11 discontinued glucocorticoid replacement after 2 years. The remaining five patients receiving bilateral total adrenalectomy required 0.5-0.75 mg of dexamethasone permanently. No open conversions, no deaths or no adrenal insufficiencies were encountered. CONCLUSIONS: LSBA represents a safe and viable treatment option for selected patients with bilateral adrenal disease.


Asunto(s)
Adenoma/cirugía , Neoplasias de las Glándulas Suprarrenales/cirugía , Adrenalectomía , Laparoscopía , Feocromocitoma/cirugía , Adenoma/metabolismo , Adenoma/patología , Neoplasias de las Glándulas Suprarrenales/patología , Adulto , Anciano , Aldosterona/biosíntesis , Pérdida de Sangre Quirúrgica , Síndrome de Cushing/cirugía , Dexametasona/uso terapéutico , Estudios de Factibilidad , Femenino , Glucocorticoides/uso terapéutico , Humanos , Masculino , Persona de Mediana Edad , Tratamientos Conservadores del Órgano , Feocromocitoma/patología , Factores de Tiempo
17.
J Urol ; 184(4): 1413-8, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20727545

RESUMEN

PURPOSE: We evaluated the association of nocturia with fracture and death in a large, community based sample of Japanese individuals 70 years old or older. MATERIALS AND METHODS: The baseline in this population based study was determined in 2003 by an extensive health interview with each participant. In this study we followed 784 individuals with a mean ± SD age of 76.0 ± 4.6 years (range 70 to 97). Information on mortality and fracture during the study period was provided by the National Health Insurance system and details on fractures were collected from medical records. We compared the risk of bone fracture and death with or without nocturia in a multivariate Cox proportional hazard model. RESULTS: Nocturia (2 or greater voids per night) was present in 359 of the 784 participants (45.7%). Fracture was observed in 41 cases, including 32 fall related cases. For all fractures and fall related fractures with nocturia the HR was 2.01 (95% CI 1.04-3.87) and 2.20 (95% CI 1.04-4.68, each p = 0.04). Death occurred in 53 cases. The mortality rate in individuals with nocturia was significantly higher than in those without nocturia. For mortality in patients with nocturia the age-gender adjusted HR was 1.91 (95% CI 1.07-3.43, p = 0.03). Even when further adjusted for diabetes, smoking status, history of coronary disease, renal disease and stroke, tranquilizers, hypnotics and diuretics, the positive relationship was unchanged (HR 1.98, 95% CI 1.09-3.59, p = 0.03). CONCLUSIONS: During a 5-year observation period elderly individuals with nocturia were at greater risk for fracture and death than those without nocturia.


Asunto(s)
Accidentes por Caídas/mortalidad , Accidentes por Caídas/estadística & datos numéricos , Fracturas Óseas/complicaciones , Fracturas Óseas/epidemiología , Nocturia/epidemiología , Anciano , Anciano de 80 o más Años , Estudios de Cohortes , Femenino , Fracturas Óseas/mortalidad , Humanos , Japón , Masculino , Nocturia/complicaciones
18.
Int Urogynecol J ; 21(5): 595-601, 2010 May.
Artículo en Inglés | MEDLINE | ID: mdl-20062975

RESUMEN

INTRODUCTION AND HYPOTHESIS: We created a rat model with a retroflexed bladder that mimicked the loss of the posterior urethrovesical angle and compared the results with sham-surgery rats for the establishment of rat models of stress urinary incontinence. METHODS: The retroflexed bladder was created by stitching the bladder posteriorly to the psoas muscle. Sneeze-induced urethral pressure response and urethral baseline pressure were measured using a microtip-transducer catheter and leak point pressures induced by sneezing, the Crede maneuver, and the vertical tilt table method were measured via a supra-pubic cystostomy. RESULTS: In rats with a retroflexed bladder, both urethral pressure response and sneeze-induced leak point pressure were significantly decreased. CONCLUSION: A retroflexed bladder may cause stress urinary incontinence by attenuating the sneeze-induced active urethral closure mechanism. Urethral pressure response restored by resumption of the posterior urethrovesical angle would explain why no sling tension is needed to treat the stress urinary incontinence.


Asunto(s)
Modelos Animales de Enfermedad , Animales , Femenino , Presión , Ratas , Ratas Sprague-Dawley , Vejiga Urinaria/anomalías , Incontinencia Urinaria de Esfuerzo/etiología
19.
J Clin Neurosci ; 16(10): 1330-3, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19577478

RESUMEN

Magnetoencephalography (MEG) was used to measure the somatosensory evoked fields in six healthy males undergoing sacral surface therapeutic electrical stimulation, a recently introduced treatment for chronic urinary dysfunction. This study was performed to investigate the utility of MEG to optimize the stimulation parameters. Strong or weak electrical stimuli were applied to small or large surface electrodes placed over the bilateral sacral surfaces. The peak latency and strength of the equivalent current dipole were evaluated at the first peak originating from the primary somatosensory cortex (M30). There was no difference in M30 latency in response to stimulation intensity or electrode size. However, a larger equivalent current dipole strength was obtained in response to higher stimulus intensities, which indicated a more effective stimulus on the sacral surface. The present MEG study shows that stronger stimuli given through large electrodes evoke larger responses than small stimuli through small electrodes. The study also suggests that MEG can be used as an objective tool to monitor whether therapeutic stimulation parameters are appropriate.


Asunto(s)
Estimulación Eléctrica/métodos , Potenciales Evocados Somatosensoriales/fisiología , Corteza Somatosensorial/fisiología , Adulto , Electrodos , Humanos , Magnetoencefalografía/métodos , Masculino , Persona de Mediana Edad , Tiempo de Reacción/fisiología , Región Sacrococcígea/fisiología
20.
Int J Urol ; 16(1): 101-4, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19120530

RESUMEN

OBJECTIVES: Although the artificial urinary sphincter (AUS) is one of the most effective surgical treatments for severe urinary incontinence, little is known about its use in Japan. A nationwide survey was done to determine contemporary trends in AUS use and its long-term durability. METHODS: Data on AUS units sold in Japan were provided directly by Takai Hospital Supply Co., Ltd., Tokyo, Japan, and a survey form was sent to all 44 institutes where AUS implantation had been carried out. The survey included various demographic and preoperative variables, surgical variables, and postoperative outcomes. RESULTS: Between 1994 and 2007, a total of 100 AUS devices had been provided in Japan. Of the 44 institutes, 24 responded to the survey, and a total of 64 patients were enrolled in the study. Post-urological surgery incontinence accounted for 81.3% of the indications. During the mean follow-up of 50 months, mechanical failure occurred in four (6.2%), and the device was removed in 13 (20.3%) due to infection (14.0%), erosion (4.7%), or urination difficulty (1.5%). Of the 58 patients evaluated, 91.4% reported social continence. Five- and 10-year failure-free rates were 74.8% and 70.1%, respectively. On multivariate analysis, operative time was an independent predictor of treatment failure (P = 0.0334). CONCLUSIONS: Considering recent trends in prostate surgery, the AUS may be significantly underused in Japan. Although excellent long-term durability has been achieved, a learning effect appears to be evident. The Japanese urological community needs to provide appropriate patients with this treatment option.


Asunto(s)
Esfínter Urinario Artificial/estadística & datos numéricos , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Encuestas Epidemiológicas , Humanos , Japón , Masculino , Persona de Mediana Edad , Implantación de Prótesis/estadística & datos numéricos , Implantación de Prótesis/tendencias , Resultado del Tratamiento , Incontinencia Urinaria/cirugía , Esfínter Urinario Artificial/tendencias , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA